Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.

MLA

Kartolo, Adi, et al. “Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.” Current Oncology, vol. 29, no. 3, Mar. 2022, pp. 1501–13. EBSCOhost, https://doi.org/10.3390/curroncol29030126.

APA

Kartolo, A., Deluce, J., Hopman, W. M., Liu, L., Baetz, T., Ernst, S., & Lenehan, J. G. (2022). Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma. Current Oncology, 29(3), 1501–1513. https://doi.org/10.3390/curroncol29030126

Chicago

Kartolo, Adi, Jasna Deluce, Wilma M. Hopman, Linda Liu, Tara Baetz, Scott Ernst, and John G. Lenehan. 2022. “Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.” Current Oncology 29 (3): 1501–13. doi:10.3390/curroncol29030126.